STAT+: Bladder cancer immunotherapy from CG Oncology reduced risk of tumor recurrence
CG Oncology's bladder cancer immunotherapy reduced risk of tumor recurrence by 68% — results that may change how physicians treat certain patients.
We haven't written up this one. STAT News has the full story — the link below goes straight to it.